D. Zhong

发表

OA01.03 Benmelstobart with Anlotinib plus Chemotherapy as First-line Therapy for ES-SCLC: A Randomized, Double-blind, Phase III Trial

R. Wu, R. Yang, D. Lin, 2023, Journal of Thoracic Oncology.

OA01.06 First-Line Chemotherapy With or Without Tislelizumab for Extensive-Stage Small Cell Lung Cancer: RATIONALE-312 Phase 3 Study

W. Zheng, S. Leaw, D. Huang, 2023, Journal of Thoracic Oncology.